1732-53-2

4-Isothiazolecarboxylic acid, 3-methyl-5-phenyl-

4(3H)-Quinazolinone,3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-6,7-dimethoxy-2-methyl-, monohydrochloride

4(3H)-Quinazolinone,6-methoxy-2-methyl-3-[4-[3-(1-pyrrolidinyl)propoxy]phenyl]-

4-Piperidinol,1-[[2-[(Z)-[5-[[(2,6-dichlorophenyl)methyl]sulfonyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene]methyl]-5-methyl-1H-pyrrol-3-yl]carbonyl]-

4(3H)-Quinazolinone,2-methyl-3-[4-[3-(1-piperidinyl)propoxy]phenyl]-6-(4-pyridinyl)-

4-Piperidinol, 4-(1H-indol-4-yl)-1-(phenylmethyl)-, hydrochloride

4(3H)-Quinazolinone,7-[(3-fluorophenyl)methoxy]-3-(2-methoxyethyl)-2-methyl-

4(3H)-Quinazolinone,6-bromo-3-[[(3-nitrophenyl)methylene]amino]-2-phenyl-

4-Piperidinol,1-[[(3S,4S)-1-[(1S)-1-cyclohexyl-2-hydroxyethyl]-4-phenyl-3-pyrrolidinyl]methyl]-4-(3-phenylpropyl)-

4(3H)-Quinazolinone,3-[(3,3-diphenyl-2-propenylidene)amino]-2-methyl-

4-Piperidinol,1-[[1-[7-[(2-chloro-6-fluorophenyl)methyl]-2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl]-4-piperidinyl]carbonyl]-

4(3H)-Quinazolinone,3-[4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl]-2,5-dimethyl-

4(3H)-Quinazolinone,3-[[(4-fluorophenyl)methylene]amino]-6-iodo-2-methyl-

4-Piperidinol, 4-(1H-indol-4-yl)-

4(3H)-Quinazolinone,3-[[(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene]amino]-2,5-dimethyl-

4(3H)-Quinazolinone,6-amino-2-methyl-3-[4-[3-(1-piperidinyl)propoxy]phenyl]-

4(3H)-Quinazolinone,3-(4-bromophenyl)-2-[2-(4-methoxyphenyl)ethenyl]-

4(3H)-Quinazolinone,3-[2-(dimethylamino)ethyl]-2-(1,3-dimethyl-1H-pyrazol-5-yl)-

4(3H)-Quinazolinone,3-[2-(4-fluorophenyl)ethyl]-2-[(4-methyl-1-piperazinyl)methyl]-7-nitro-

4-Piperidinol,1-[(1,4-dihydro-7-hydroxy-4-oxo-2-quinolinyl)carbonyl]-4-(phenylmethyl)-

4(3H)-Quinazolinone,3-[3-methoxy-4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-6-phenoxy-

4(3H)-Quinazolinone,3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-6,7-dimethoxy-2-methyl-, monohydrochloride

4-Piperidinol, 2,6-diethyl-2,3,6-trimethyl-, carbonate (2:1) (ester)

4-Piperidinol,1-[4-(dimethylamino)-2-butynyl]-3-methyl-2,6-diphenyl-4-(phenylethynyl)-

4-Piperidinol,1-(2-ethoxyethyl)-2,5-dimethyl-4-[3-(4-methylphenoxy)-1-propynyl]-,benzoate (ester), (2R,4S,5S)-rel-

4(3H)-Quinazolinone,3-[[(3-chlorophenyl)methylene]amino]-6-iodo-2-methyl-

4(3H)-Quinazolinone,6-fluoro-3-[3-methoxy-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-7-(4-morpholinyl)-2-(phenylmethyl)-

4(3H)-Quinazolinone,3-[[(2,4-dichlorophenyl)methylene]amino]-6-iodo-2-methyl-

4(3H)-Quinazolinone,3-[[(2,4-dichlorophenyl)methylene]amino]-2-(4-nitrophenyl)-

4(3H)-Quinazolinone,3-[4,5-dihydro-5-oxo-2-phenyl-4-(phenylmethylene)-1H-imidazol-1-yl]-6-iodo-2-methyl-

4(3H)-Quinazolinone,3-[[(3-chlorophenyl)[(4-chlorophenyl)thio]methyl]amino]-6-iodo-2-methyl-

4(3H)-Quinazolinone,2-methyl-3-[2-[3-(1-piperidinyl)propoxy]-5-pyrimidinyl]-

4-Piperidinol,1-[[4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-(2-pyridinylmethoxy)-5-pyrimidinyl]carbonyl]-

4-Piperidinol,3-methyl-2,6-diphenyl-4-(phenylethynyl)-1-[4-(1-piperidinyl)-2-butynyl]-

4(3H)-Quinazolinone,3-[4-[(1-cyclopentyl-4-piperidinyl)oxy]phenyl]-2,5-dimethyl-

4(3H)-Quinazolinone,3-(1H-indazol-6-yl)-2-[2-(4-methoxyphenyl)ethenyl]-

4(3H)-Quinazolinone,3-[[[5-[[[4-(dimethylamino)phenyl]methylene]amino]-1,3,4-thiadiazol-2-yl]methyl]amino]-2-methyl-

1732-53-2 msds

CAS No 1732-53-2 supplier

CASNo 1732-53-2 distributor

CAS # 1732-53-2 manufacturer

CAS Number 1732-53-2 safety

CAS RN 1732-53-2 wholesale

2026-10-09 4-Isothiazolecarboxylic acid, 3-methyl-5-phenyl-,CAS No.1732-53-2,Formula:C11H9NO2S. Find Related Products for Bulk Production or Scientific Research